มะเร็งตับอ่อน
รายการอ้างอิง

1 2 3 4 5 6 7  "Pancreatic Cancer Treatment (PDQ®) Patient Version". National Cancer Institute. National Institutes of Health. 17 April 2014. เก็บจากแหล่งเดิมเมื่อ 5 July 2014. สืบค้นเมื่อ 8 June 2014.
1 2 3 4 5 6  Ryan DP, Hong TS, Bardeesy N (September 2014). "Pancreatic adenocarcinoma". The New England Journal of Medicine. 371 (11): 1039–49. doi:10.1056/NEJMra1404198. PMID 25207767.
1 2 3 4  Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (September 2013). "Recent progress in pancreatic cancer". CA: A Cancer Journal for Clinicians. 63 (5): 318–48. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
1 2 3  Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (สิงหาคม 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607–20. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 12 มกราคม 2015.
1 2  "Can pancreatic cancer be prevented?". American Cancer Society. 11 June 2014. เก็บจากแหล่งเดิมเมื่อ 13 November 2014. สืบค้นเมื่อ 13 November 2014.
1 2  "Cancer Facts & Figures 2010" (PDF). American Cancer Society. 2010. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 14 มกราคม 2015. สืบค้นเมื่อ 5 ธันวาคม 2014. See p. 4 for incidence estimates, and p. 19 for survival percentages.
↑  Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A,  และคณะ (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
1 2  Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A,  และคณะ (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
↑  "What is Cancer? Defining Cancer". National Cancer Institute, National Institutes of Health. 7 March 2014. เก็บจากแหล่งเดิมเมื่อ 25 June 2014. สืบค้นเมื่อ 5 December 2014.
1 2 3 4 5 6 7 8 9 10 11  World Cancer Report. World Health Organization. 2014. Chapter 5.7. ISBN 978-92-832-0429-9.
1 2 3 4 5  Unless otherwise specified in boxes, reference is: Pishvaian MJ, Brody JR (March 2017). "Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer". Oncology. 31 (3): 159–66, 168. PMID 28299752.
1 2 3 4 5  Bond-Smith G, Banga N, Hammond TM, Imber CJ (May 2012). "Pancreatic adenocarcinoma". BMJ. 344 (may16 1): e2476. doi:10.1136/bmj.e2476. PMID 22592847. S2CID 206894869.
↑  "Draft Recommendation Statement: Pancreatic Cancer: Screening – US Preventive Services Task Force". www.uspreventiveservicestaskforce.org. สืบค้นเมื่อ 11 February 2019.
↑  Bardou M, Le Ray I (December 2013). "Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies". Best Practice & Research. Clinical Gastroenterology. 27 (6): 881–92. doi:10.1016/j.bpg.2013.09.006. PMID 24182608.
↑  "Cancer facts and figures – Why we exist – Pancreatic Cancer Research Fund". www.pcrf.org.uk. สืบค้นเมื่อ 5 April 2019.
↑  "Pancreatic Cancer – Cancer Stat Facts". SEER (ภาษาอังกฤษ). สืบค้นเมื่อ 4 April 2019.
↑  "Pancreatic Cancer Treatment (PDQ®) Health Professional Version". National Cancer Institute. National Institutes of Health. 21 February 2014. เก็บจากแหล่งเดิมเมื่อ 22 October 2014. สืบค้นเมื่อ 24 November 2014. "The highest cure rate occurs if the tumor is truly localized to the pancreas; however, this stage of disease accounts for less than 20% of cases. In cases with localized disease and small cancers (<2 cm) with no lymph-node metastases and no extension beyond the capsule of the pancreas, complete surgical resection is still associated with a low actuarial five-year survival rate of 18% to 24%."
↑  Harris RE (2013). "Epidemiology of pancreatic cancer". Epidemiology of Chronic Disease. Jones & Bartlett. pp. 181–190. ISBN 978-0-7637-8047-0. เก็บจากแหล่งเดิมเมื่อ 24 มิถุนายน 2016.
↑  Öberg K, Knigge U, Kwekkeboom D, Perren A,  และคณะ (ESMO Guidelines Working Group) (October 2012). "Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7 (suppl 7): vii124-30. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
↑
↑  "Chapter 15; Pancreas" (PDF). Manual for Staging of Cancer (2nd ed.). American Joint Committee on Cancer. pp. 95–98. เก็บ (PDF)จากแหล่งเดิมเมื่อ 29 พฤศจิกายน 2014. See p. 95 for citation regarding "... lesser degree of involvement of bones and brain and other anatomical sites."
↑  Skafida E, Grammatoglou X, Glava C, Zissis D, Paschalidis N, Katsamagkou E,  และคณะ (February 2010). "Adenosquamous carcinoma of the pancreas: a case report". Cases Journal. 3 (1): 41. doi:10.1186/1757-1626-3-41. PMC 2825199. PMID 20205828.
↑  Diana Agostini-Vulaj. "Pancreas – Exocrine tumors / carcinomas – Intraductal papillary mucinous neoplasm (IPMN)". Pathology Outlines. Topic Completed: 1 July 2018. Revised: 9 March 2020
↑  Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G,  และคณะ (January 2016). "Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting". Annals of Surgery. 263 (1): 162–77. doi:10.1097/SLA.0000000000001173. PMC 4568174. PMID 25775066.